"There is a need to rebalance pharmaceutical systems in the European Region." Yannis Natsis explains how collaboration with different sectors is crucial if we want to ensure sustainable access to novel medicines in the European Region. 🔗 bit.ly/NMPjuly2024 #WHONMP EU Social Insurance

2 days of dialog at WHO/Europe this week, on widening affordable access to lifesaving medicines for patients across our Region - including those in small countries. We're convening governments, pharma & civil society under our Novel Medicines Platform: who.int/europe/news/it…

Hans Kluge Natasha Azzopardi Muscat Concerned about the high costs of novel medicines? So are we. That’s why we’re bringing together stakeholders to address this issue through the Novel Medicines Platform. TODAY: Join us live until 10:20 am CEST to learn more ➡️ bit.ly/NMPjuly2024 #WHONMP Natasha Azzopardi Muscat

The demand for specialized drugs is rising, but high costs remain a challenge for countries. The Novel Medicines Platform will help countries improve access and sustainability of our health-care systems: bit.ly/4csfp5o #WHONMP

WHO/Europe Affordable Medicines Europe Medicines for Europe Natasha Azzopardi Muscat Bettina Ryll EU Medicines Agency EU One Health Sandra Gallina Stella Kyriakides EFPIA xxx bokep🇬🇧 The Novel Medicines Platform, convened by WHO/Europe, provides a neutral space for all stakeholders –patients, payers, policymakers and industry– to discuss & collaborate. Let us be guided by the human condition. The common thread that binds us all. 3/ x.com/WHO_Europe/sta…

Investments in biopharmaceutical research have led to advancements in disease prevention, screening, diagnosis, and treatment. The Novel Medicines Platform is an opportunity to ensure these benefits reach everyone: bit.ly/NMPjuly2024 #WHONMP

Enormous gratitude, whether EFPIA or @ organisations, 4 your leadership & vision not to mention drive Hans Kluge. You have moved us from being divided in trenches to working together in the weeds. #Imagine what we can do together as a health community for #accesstomeds #WHONMP

Without your dedication, diplomacy, clarity & vision, we would not be where we are as #health #stakeholders in the #WHONMP work Natasha Azzopardi Muscat. You truly are an incredible force for good & we are grateful for your commitment as EFPIA in the name of #accesstomeds #wewontrest

Transparency, innovation, commitment. The pillars underpinning the Novel Medicines Platform dialogue at WHO/Europe. The NMP is precisely the policy lab we need to increase access to novel medicines, including those for rare diseases. 4/

WHO/Europe Natasha Azzopardi Muscat EU Medicines Agency LSE Health Policy Precision for Medicine, Oncology and Rare Disease Affordable Medicines Europe Nature Medicine WHO/Europe has convened the Novel Medicines Platform. But success depends on governments, the pharmaceutical industry & civil society players whose dialogue must now lead to concrete steps across the Region. Wishing NMP stakeholders all strength in their crucial mission! 5/

Wrapping up Day 1 of the Novel Medicines Platform meeting in Copenhagen. Country representatives, industries, civil society organizations, and partners have come together to discuss actions to improve access to novel medicines in the WHO European Region: bit.ly/NMPjuly2024

Key takeaways: 📌The Novel Medicines Platform is a much-needed space for dialogue and collaboration. 📌It’s crucial for transforming health systems and advancing our shared goal of improving access to medicine and advancing #UniversalHealthCoverage.

📌Topics discussed included, the need for solidarity to ensure sustainability, including horizon-scanning, managed entry agreements, early access, a focus on rare diseases and precision medicine, incentivizing R&D, and promoting equitable access across the Region.

Today, after 2 years hard work the #NMP brought public & private sector, patients & funders together. We expect to agree on concrete proposals to increase access to affordable medicines.🇨🇿is chairing working group 2 on solidarity. 🙏Jakub Dvořáček for leadership & WHO/Europe

💊 💉 The Novel Medicines Platform is working to ensure fair access to novel medicines across the WHO European Region. Discover how on 2 July. Join us online 9:00 -10:20 AM CEST! 📹 🔴 bit.ly/NMPjuly2024 #WHONMP Hans Kluge Natasha Azzopardi Muscat

Great start to Day 2 of WHO/Europe #WHONMP consensus building mtg wt presentations from the working group focused on #transparency led by Francis Arickx with Sabine Volker & Kathleen Grieve of MSD Europe for EFPIA . Inspiring to see the work of all WGs to improve #accesstomeds

Two days, 30 countries, six industry organizations, 12 partners, 14 NGOs. The Novel Medicines Platform is bringing all stakeholders to the same table to discuss how to improve access to novel medicines in the WHO European Region: bit.ly/3xSQNDw Natasha Azzopardi Muscat #WHONMP

After 1.5 years it was very fulfilling to see the hard work being brought to life this past week and see the ideas of the #WHONMP stakeholders that have the potential to change the status quo and improve access to patients. Looking forward to implementing WHO/Europe

As Dr Tedros says: "UHC is ultimately a political choice". Parliamentarians are crucial in making UHC happen - thank you UHC2030 and UNITE 🙏🙏🙏

At the 20th Shanghai Forum, I spoke about how the WHO European Region is transforming health systems through digitalization & AI — and how we can partner with China 🇨🇳 to go even further, together. There is strong momentum in our Region to harness digital health and #AI. I